Loading
An trial of NHWD-870 run by Hunan Province Tumor Hospital, of unknown status on the registry.
Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement is an interventional study registered as NCT06073938 by Hunan Province Tumor Hospital, with 30 participants planned, started 2022-09-20. Conditions recorded: Advanced Solid Tumors or Lymphomas. Interventions recorded: NHWD-870.
Shares NHWD-870, Zhejiang Wenda Pharma and the tag pipeline.
Shares Zhejiang Wenda Pharma and the tag pipeline.
Shares Zhejiang Wenda Pharma and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/